SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflixs upcoming Q3 earnings report is the main focus, with traders watching guidance, subscriber engagement and advertising growth after a steep share-price decline and recent layoffs and content-leadership changes. Views are split between hopes for a rebound if results or outlook exceed subdued expectations and bets on further losses if growth concerns persist.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Modernas rally is drawing attention as traders position around the full Phase 3 melanoma cancer-vaccine data presentation at ESMO, following previously reported positive topline results. Bulls see the readout as validation of the oncology pipeline, while skeptics warn that expectations and valuation are elevated and debate whether the event could prompt profit-taking.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

SRPTs sharp rebound is drawing attention, with traders attributing the move to possible short covering and technical buying rather than a confirmed new company announcement. The broader debate centers on upcoming DM1 and FSHD siRNA data: Novartis/Aviditys DM1 trial failure raised concerns about whether target knockdown can translate into patient benefit, while some traders argue Sareptas distinct delivery approach and the loss of a competitor could be favorable.

Sea Ltd. is an internet and mobile platform company, which engages in the provision of online gaming services. It operates through the following segments: Digital Entertainment, E-Commerce, and Digital Financial Services. The Digital Entertainment segment offers and develops mobile and PC online games. The E-Commerce segment manages a third-party marketplace through the Shopee mobile app and websites that connect buyers and sellers. The Digital Financial Services segment includes a variety of payment services and loans to individuals and businesses through SeaMoney. Sea was founded by Xiao Dong Li, Gang Ye, and Jing Ye Chen on May 8, 2009 and is headquartered in Singapore.

Sea Ltd - ADR

Seas sharp selloff and fresh low are being linked by traders to plans for a potential Monee listing and the launch of Sea Cloud, alongside concerns about spending and competition in e-commerce. Some see a Monee separation as value-unlocking, while others view the plans and uncertainty around them as a reason to sell; claims of further undisclosed bad news remain speculation.

GE Aerospace is an American aircraft company, which engages in the provision of jet and turboprop engines, as well as integrated systems for commercial, military, business, and general aviation aircraft. The firm's portfolio of brands includes Avio Aero, Unison, GE Additive, and Dowty Propellers. It operates through the following segments: Commercial Engines and Services, Defense and Propulsion Technologies, and Corporate and Other. The Commercial Engines and Services segment is involved in the design, development, manufacturing, and servicing of jet engines for commercial airframes, as well as business aviation and aeroderivative applications. The Defense and Propulsion Technologies segment offers defense engines and critical aircraft systems. The Corporate and Other segment relates to corporate functions and operations costs. The company was founded by Thomas Alva Edison in 1878 and is headquartered in Evendale, OH.

GE Aerospace

GE Aerospaces earnings beat and raised outlook drew attention as shares sold off despite strong demand, with traders frustrated by the reaction. The debate centers on whether higher costs, weaker cash generation and an insurance loss outweigh the stronger orders and guidance.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

Attention centers on TG Therapeutics MSToronto presentations, especially initial Phase 1 azer-cel data in progressive MS and additional BRIUMVI results, with commercial growth and a future subcutaneous formulation also part of the bullish case. Traders are anticipating a catalyst-driven move, though some caution that the azer-cel results remain uncertain and complain that the shares have struggled to break out of a trading range.

General Motors Co. engages in the designing, manufacturing, and selling of trucks, crossovers, cars, and automobile parts, and in providing software-enabled services and subscriptions. It operates through the following segments: GMNA, GMI, Cruise, and GM Financial. The company was founded by William C. Durant on September 16, 1908 and is headquartered in Detroit, MI.

General Motors Company

GM is selling off despite a third-quarter earnings beat and a new buyback authorization, as traders focus on narrowed full-year profit guidance with an unchanged midpoint and weaker vehicle sales. Some view the drop as overdone given the stronger cash-flow outlook and buyback, while others see the outlook as too cautious to offset the earnings-day disappointment.

Myriad Genetics, Inc. is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. It develops and commercializes molecular tests that help patients and providers uncover genetic insights. The company was founded by Walter A. Gilbert, Mark H. Skolnick, and Peter D. Meldrum in May 1991 and is headquartered in Salt Lake City, UT.

Myriad Genetics, Inc.

Myriad Genetics agreement to sell its prenatal testing business to Labcorp is driving a sharp rally, with traders viewing the cash proceeds as a balance-sheet and strategic boost. Others question the deal because the divested unit contributes revenue, raising concerns about debt and the outlook for the remaining business; some traders are also taking profits after the surge.

The Boeing Co. is an aerospace company, which engages in the manufacture of commercial jetliners and defense, space, and security systems. It operates through the following segments: Commercial Airplanes (BCA), Defense, Space and Security (BDS), and Global Services (BGS). The Commercial Airplanes segment includes the development, production, and market of commercial jet aircraft and provides fleet support services, principally to the commercial airline industry worldwide. The Defense, Space and Security segment refers to the research, development, production and modification of manned and unmanned military aircraft and weapons systems for global strike, including fighter and combat rotorcraft aircraft and missile systems, global mobility, including tanker, rotorcraft and tilt-rotor aircraft, and airborne surveillance and reconnaissance, including command and control, battle management and airborne anti-submarine aircraft. The Global Services segment provides services to commercial and defense customers. The company was founded by William Edward Boeing on July 15, 1916, and is headquartered in Arlington, VA.

Boeing Co.

Boeing Co

Traders are focused on an expected FAA certification announcement for Boeings 737 MAX 10, a long-delayed milestone they see as potentially easing a key overhang. Reactions are divided: some expect the approval to improve sentiment and support future deliveries, while skeptics say it may be priced in and that production execution, delivery pace and cash generation matter more.

Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA.

Rapport Therapeutics Inc.

Rapport Therapeutics Inc

RAP-219s Phase 2 trial in bipolar mania met its primary and secondary endpoints, prompting bullish trading and analyst optimism, including an upgrade. The community is divided over the modest placebo-adjusted benefit and concerns about agitation and discontinuations; the initial surge faded as traders debated whether the data justify further upside.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

SNAL Stock Dips 41% in a Month: Should Investors Buy, Sell, or Hold?

SNAL's 41% slide puts its content pipeline and low valuation in focus, but weak bookings, negative EBITDA and Nasdaq compliance risks loom.

SHAREHOLDER ALERT: Kaskela Law Announces Investigation of Playtika Holding Corp. (NASDAQ: PLTK) and Encourages Current Playtika Shareholders to Contact the Firm

Kaskela Law announces that it is investigating Playtika Holding Corp. (NASDAQ: PLTK) (Playtika) on behalf of the companys current shareholders. Click here for additional information: https://kaskelalaw.com/case/playtika-holding/ The investigation seeks to determine whether Playtika and/or the...

Snail Stock Tumbles 38% in a Month: Buy the Dip, Hold or Sell?

SNAL's 38% monthly plunge reflects weaker ARK sales and bookings, but new content, Bellwright and lower licensing costs could aid recovery.

Should You Buy, Sell or Hold Snail Stock Before Q2 Earnings Release?

SNAL's ARK content and deferred revenues could lift Q2 sales, but heavy development spending and reliance on ARK cloud its outlook.

Playtika (PLTK) Reports Q2 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for Playtika (PLTK) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Playtika Holding (PLTK) Q2 Earnings Match Estimates

Playtika (PLTK) delivered earnings and revenue surprises of 0.00% and +2.48%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Is Playtika (PLTK) a Great Value Stock Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Is Playtika (PLTK) Outperforming Other Consumer Discretionary Stocks This Year?

Here is how Playtika Holding (PLTK) and Viking Holdings (VIK) have performed compared to their sector so far this year.

Should Value Investors Buy Playtika (PLTK) Stock?

Should Value Investors Buy PENN Entertainment, Inc. (PENN) Stock?

Playtika Holding Corp. engages in the development of mobile games. It builds live game operations services and a proprietary technology platform to support its portfolio of games. Its games include Slotomania, Bingo Blitz, House of Fun, Solitaire Grand Harvest, June's Journey, Caesars Slots, Best Friends, Board Kings, and Redecor. The company was founded by Robert Antokol and Uri Shahak in 2010 and is headquartered in Herzliya, Israel.

Playtika Holding Corp

Playtika Stock On Track To Record Biggest Single-Day Gain Ever After BofA’s Double Upgrade: Retail’s Exuberant

Equity

Neutral Sentiment

Shares of Playtika Holding Corp. (PLTK) surged on Wednesday despite the tech sector's weakness following&nbsp;BofA Securities' upbeat commentary.Israel-based Playtika is a mobile game developer that owns a portfolio of casual and social casino-themed games and distributes them through web, mobile, and direct-to-consumer platforms.On Wednesday, BofA analysts double upgraded&nbsp;<a href="https://stocktwits.com/symbol/PLTK">Playtika stock&nbsp;</a>to ‘Buy’ from ‘Underperform’ and upped the price target to $6.50 from $6, TheFly reported.&nbsp;The brokerage said Playtika has the highest profitability in the industry, with 30% earnings before interest, taxes, depreciation, and amortization (EBITDA) margins, and it is the industry’s largest direct-to-consumer platform.&nbsp;It also noted that the company has three of the largest and longest-running franchises in mobile gaming history.BofA thinks the downside to the shares is limited due to the next 12 months' free cash flow yield remaining at an all-time high of 21% and the 9% dividend yield.According to the analyst, the recent "share price dislocation" has been driven by the exit of a large shareholder in low trading liquidity, concerns that Playtika's transition to growth has taken too long, and investor preference for mobile ad network assets over publishers.Playtika stock, which moved sideways from the start of 2025, pulled back along with the broader market weakness in mid-February. The stock opened sharply lower on Feb. 27, when the company reported its fourth-quarter results that showed an earnings miss.The stock has been trending lower since.On Stocktwits, retail sentiment toward Playtika stock reversed to ‘extremely bullish’ (87/100) from ‘bearish’ a day ago, and the message volume improved notably to ‘extremely high.’<figure class="image"><img style="aspect-ratio:632/140;" src="https://news.stocktwits-cdn.com/pltk_sentiment_png_6a2083a76f.webp" alt="pltk-sentiment.png" width="632" height="140"><figcaption>PLTK sentiment and message volume March 26, as of 11:56 am ET | Source:&nbsp;Stocktwits</figcaption></figure>While stating that they took some profits, a bullish watcher said the stock could go higher.<stembedurl>https://stocktwits.com/dhlskurp/message/609275122</stembedurl>Playtika climbed 21.94% to $5.37 by Wednesday noon. If the gains are sustained through the session, the stock is on track to record its biggest one-day jump ever, according to Koyfin. The stock is down over 20% this year.The Koyfin-compiled consensus price target for the stock is $8.20, implying scope for an 86% upside potential.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/palo-altos-retail-followers-cheer-new-nhl-partnership/chJG6sERb3k">Palo Alto Stock’s Retail Followers Cheer New NHL Partnership, But Shares Slip Amid Tech Sell-Off</a>

 In this photo illustration, the logo of Playtika is seen displayed on a mobile phone screen.

 BofA said Playtika has the highest profitability in the industry, with 30% EBITDA margins, and it is the industry’s largest direct-to-consumer platform. 

iShares Russell Mid-Cap ETF

SPDR S&P Software & Services ETF

Double beat (rev + EPS)

Revenue beat, EPS miss

EPS beat, revenue miss

Double miss

SpaceX ($SPCX) reports earnings after the close today. What do you expect?

Stocktwits

SpaceX

) reports earnings after the close today. What do you expect?

Current Price	$2.07
Prev Close	$2.07
Open	$2.10
Dividend Yield	10.13%
50-Day Moving Average	$2.28
Beta	1.03
Avg. Volume	1.18M
PE Ratio	-2.79

52-Week High	$4.42
52-Week Low	$2.04
Market Capitalization	$789.54M
EPS (Annual)	-$0.5492
Price to Book	-1.97
Revenue Per Employee	$867,842.52

Feed

News

Sentiment

Earnings

Fundamentals

Info

PLTK Fundamentals